To accurately evaluate treatments of generalized social phobia, it is
not sufficient that measures be reliable and valid, they also must be
sensitive to treatment-related changes. The present study evaluated th
e sensitivity of the following five measures: (a) The Social Phobia sc
ale from the Social Phobia and Anxiety Inventory (SPAI-SP), (b) the SP
AI difference score (SPAI-D), (c) the short form of the Fear of Negati
ve Evaluation Scale (FNE-S), (d) the Social Phobia scale from the Fear
Questionnaire (FQ-SP), and (e) peak anxiety during an impromptu speec
h task. Unmedicated people with generalized social phobia (N = 60) wer
e randomly allocated to one of the following two treatments: (a) eight
sessions of associative therapy (AT; i.e., free association to social
ly relevant thoughts and memories), followed by eight sessions of in v
ivo exposure (EXP); or (b) eight sessions of cognitive restructuring (
CR), followed by eight sessions of EXP. Outcome measures were complete
d on entry into the study, after completing AT or CR (post-I), after c
ompleting EXP (post-II), and at 3-month follow-up. For each outcome me
asure, effect sizes were computed for post-I, post-II, and follow-up.
The SPAI-SP and SPAI-D tended to have the largest effect sizes, and th
e FNE-S and FQ-SP tended to yield the smallest effects. The results ad
d to the growing body of research supporting the usefulness of the SPA
I scales as a treatment-outcome measure for studies of generalized soc
ial phobia.